These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24056092)

  • 1. Evaluation of the light scattering and the turbidity microtiter plate-based methods for the detection of the excipient-mediated drug precipitation inhibition.
    Petruševska M; Urleb U; Peternel L
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1148-56. PubMed ID: 24056092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a high-throughput screening method for the detection of the excipient-mediated precipitation inhibition of poorly soluble drugs.
    Petruševska M; Urleb U; Peternel L
    Assay Drug Dev Technol; 2013 Mar; 11(2):117-29. PubMed ID: 23116459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using droplet-based microfluidic technology to study the precipitation of a poorly water-soluble weakly basic drug upon a pH-shift.
    Edwards F; Tsakmaka C; Mohr S; Fielden PR; Goddard NJ; Booth J; Tam KY
    Analyst; 2013 Jan; 138(1):339-45. PubMed ID: 23152955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excipient-mediated supersaturation stabilization in human intestinal fluids.
    Bevernage J; Forier T; Brouwers J; Tack J; Annaert P; Augustijns P
    Mol Pharm; 2011 Apr; 8(2):564-70. PubMed ID: 21268663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calculation of drug-polymer mixing enthalpy as a new screening method of precipitation inhibitors for supersaturating pharmaceutical formulations.
    Price DJ; Nair A; Kuentz M; Dressman J; Saal C
    Eur J Pharm Sci; 2019 Apr; 132():142-156. PubMed ID: 30877067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of surface-adsorbed excipients of various types on drug particles prepared by antisolvent precipitation using HPLC with evaporative light scattering detection.
    Zimmermann A; Elema MR; Hansen T; Müllertz A; Hovgaard L
    J Pharm Biomed Anal; 2007 Aug; 44(4):874-80. PubMed ID: 17531425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
    Linn M; Collnot EM; Djuric D; Hempel K; Fabian E; Kolter K; Lehr CM
    Eur J Pharm Sci; 2012 Feb; 45(3):336-43. PubMed ID: 22172603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: a case study.
    Li S; Pollock-Dove C; Dong LC; Chen J; Creasey AA; Dai WG
    Mol Pharm; 2012 May; 9(5):1100-8. PubMed ID: 22376012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel screening approach to identify solubility-enhancing formulations for improved bioavailability of a poorly water-soluble compound using milligram quantities of material.
    Dai WG; Dong LC; Li S; Pollock-Dove C; Chen J; Mansky P; Eichenbaum G
    Int J Pharm; 2007 May; 336(1):1-11. PubMed ID: 17178444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
    Shono Y; Jantratid E; Dressman JB
    Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination turbidity and supernatant microplate assay to rank-order the supersaturation limits of early drug candidates.
    Morrison JS; Nophsker MJ; Haskell RJ
    J Pharm Sci; 2014 Oct; 103(10):3022-32. PubMed ID: 25070886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems.
    Stillhart C; Cavegn M; Kuentz M
    J Pharm Pharmacol; 2013 Feb; 65(2):181-92. PubMed ID: 23278685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability.
    Xu L; Luo Y; Feng J; Xu M; Tao X; He H; Tang X
    Int J Pharm; 2012 Jan; 422(1-2):9-16. PubMed ID: 22001837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro kinetic method for detection of precipitation of poorly soluble drugs.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    Int J Pharm; 2005 Nov; 304(1-2):1-3. PubMed ID: 16198520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine.
    Kostewicz ES; Wunderlich M; Brauns U; Becker R; Bock T; Dressman JB
    J Pharm Pharmacol; 2004 Jan; 56(1):43-51. PubMed ID: 14980000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME).
    Dai WG; Dong LC; Shi X; Nguyen J; Evans J; Xu Y; Creasey AA
    J Pharm Sci; 2007 Nov; 96(11):2957-69. PubMed ID: 17705287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
    Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
    Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.